A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 6, 1998, Pages 497-504

  Picon, Antonio ^a   Gold, Leslie I ^b   Wang, Jingping ^c   Cohen, Alfred ^a   Friedman, Eileen ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CANCER INVASION; CELL MOTILITY; COLON CANCER; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTESTINE CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CARCINOMA; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031948084     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kingsley, D. The TGFβ superfamily new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 8: 133-146, 1994.
2. Migdalska, A., Molineux, G., Demuynck, H., Evans, G., Ruscetti, F., and Dexter, T. Growth inhibitory effects of TGFβ1 in vivo Growth Factors, 4: 239-245, 1991.
3. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., Brattain, M., and Willson, J. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability Science (Washington DC), 268: 1336-1338, 1995.
4. Hahn, S., Schutte, M., Hoque, A. T. M. S., Moskaluk, C., da Costa, L., Rozenblum, E., Weinstein, C., Fischer, A., Yeo, C., Hruban, R. H., and Kern, S. DPC4, a candidate tumor suppressor gene at human chromosome 18qa21.1. Science (Washington DC), 271: 350-353, 1996.
5. Riggins, G., Thagalingam, S., Rozenblum, E., Weinstein, C., Kern, S., Hamilton, S., Willson, J., Markowitz, S., Kinzler, K., and Vogelstein, B. Mad-related genes in the human. Nat Genet., 13: 347-349, 1996.
6. Riggins, G., Kinzler, K., Vogelstein, B., and Thagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
7. Hsu, S., Huang, F., Hafez, M., Winawer, S., and Friedman, E. Colon carcinoma cells switch their response to TGFβ1 with tumor progression. Cell Growth Differ., 5: 267-275, 1994.
8. Huang, F., Newman, E., Kerbel, R., and Friedman, E. TGFβ1 is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGFβ1 antisense expression plasmid. Cell Growth Differ., 6: 1635-1642, 1995.
9. Friedman, E., Gold, L., Klimstra, D., Zeng, Z., Winawer, S., and Cohen, A. High levels of TGFβ1 correlate with disease progression in human colon cancer. Cancer Epidemiol. Biomark. Prev., 4: 549-554, 1995.
10. Pelton, R., Saxena, B., Jones, M., Moses, H., and Gold, L. Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol., 115: 1091-1105, 1991.
11. Purchio, A., Cooper, J., Brunner, A., Lioubin, M., Gentry, L., Kovacina, K., Roth, R., and Marquardt, H. Identification of mannose-6-phosphate in two asparagine-linked sugar groups of recombinant TGFβ precursor. J. Biol. Chem., 263: 14211-14215, 1988.
12. Yan, Z., Hsu, S., Winawer, S., and Friedman, E. TGFβ1 inhibits retinoblastoma gene expression but not pRB phosphorylation in TGFβ1-growth-stimulated colon carcinoma cells. Oncogene, 7: 801-805, 1992.
13. Hafez, M., Hsu, S., Yan, Z., Winawer, S., and Friedman, E. Two roles for TGFβ1 in colon enterocytic differentiation. Cell Growth Differ., 3: 753-762, 1992.
14. Gentry, L., Lioubin, M., Purchio, A., and Marquardt, H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor β to the mature polypeptide. Mol. Cell. Biol., 8: 4162-4168, 1988.
15. Jennings, M. T., Kaariainen, I. T., Gold, L., Maciunas, R. J., and Commers, P. A. TFG beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis. Hum Pathol., 25: 464-475, 1994.
16. Gold, L., Saxena, B., Mittalk, K., Marmor, M., Goswami, S., Nactigal, L., Korc, M., and Demopoulos, R. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action Cancer Res., 54: 2347-2358, 1994.
17. Gorsch, S., Memoli, V., Stukel, T., Gold, L., and Arrick, B. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer Cancer Res., 52: 6949-6952, 1992.
18. Freiss, H., Yamanaka, Y., Buchler, M., Ebert, M., Berger, H., Gold, L., and Korc, M. Enhanced expression of TGFβ isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856, 1994.
19. Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Imai, Y., Shimomukai, H., Normura, Y., Matsuda, Y., and Matsuzama, Y. High level of TGFβ1 in patients with colorectal cancer association with disease progression Gastroenterology, 110: 375-382, 1996.
20. Robson, H., Anderson, E., James, R., and Schofield, P. TGFβ1 expression in human colorectal tumours: an independent prognostic marker m a subgroup of poor prognosis patients. Br. J. Cancer, 74: 753-758, 1996.
21. Chang, H-L., Gillett, N., Figari, I., Lopez, A., Palladino, M., and Derynck, R. Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53: 4391-4398, 1993.
22. Ruscetti, F., and Palladino, M. TGFβ and the immune system. Growth Factor Res., 3: 159-175, 1991.
23. Cui, W., Fowlis, D., Bryson, S., Duffie, E., Ireland, H., Balmain, A., and Akhurst, R. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86: 531-542, 1996.
24. Schroy, P., Carnright, K., Winawer, S., and Friedman, E. Heterogeneous responses of human colon carcinomas to hexmethylene bisacetamide. Cancer Res., 48: 5487-5484, 1988.
25. Schroy, P., Rifkin, J., Coffey, R., Winawer, S., and Friedman, E. Role of TGFβ1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res., 50: 261-265, 1990.
26. Huang, F., Hsu, S., Yan, Z., Winawer, S., and Friedman, E. The capacity for growth stimulation by TGFβ1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras. Oncogene, 9: 3701-3706, 1994.
27. Hsu, S., Huang, F., and Friedman, E. Paracnne PDGF-B increases colon cancer growth in vivo J. Cell Physiol., 165: 239-245, 1995.
28. Lindmark, G., Sundberg, C., Glimelius, B., Pahlman, L., Rubin, K., and Gerdin, B. Stromal expression of PDGFβ-receptor and PDGF B-chain in colorectal cancer Lab. Invest., 69: 682-689, 1993.
29. Sundberg, C., Ljungstrom, M., Lindmark, G., Gerdin, B., and Rubin, K. Microvascular pericytes express PDGFβ-receptors in human healing wounds and colorectal adenocarcinoma Am. J. Pathol., 143: 1377-1388, 1993.
30. Welch, D., Fabra, A., and Nakajima, M. TGFβ stimulates mammary adenocarcinoma cell invasion and melastatic potential Proc. Natl. Acad. Sci. USA, 87: 7678-7682, 1990.
31. Arteaga, C., Carty-Dugger, T., Moses, H., Hurd, S., and Pietenpol, J. TGFβ1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4: 193-201, 1993.
32. Truong, L., Kadmon, D., McCune, B., Flanders, K., Scardino, P., and Thompson, T. Association of TGFβ1 with prostate cancer Hum. Pathol., 24: 4-9, 1993.